{"transactions":[{"id":4617483,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":38541,"kind":"person","name":"Duhay Francis","position":1,"cik":"0001760582","reported_name":"Duhay Francis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-14T22:56:49.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":11,"price":11.21,"value":123.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025."}],"balance_after":2351,"source":{"system":"sec-edgar","filing":"0001493152-26-042629","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760582/000149315226042629/ownership.xml","form_type":"4"}},{"id":739142,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":38541,"kind":"person","name":"Duhay Francis","position":1,"cik":"0001760582","reported_name":"Duhay Francis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-12T20:05:29.000Z","date":"2026-06-11","kind":"sale","planned":true,"acquired":false,"shares":140,"price":10.305,"value":1442.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025."}],"balance_after":2362,"source":{"system":"sec-edgar","filing":"0001493152-26-028426","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315226028426/ownership.xml","form_type":"4"}},{"id":843503,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":38541,"kind":"person","name":"Duhay Francis","position":1,"cik":"0001760582","reported_name":"Duhay Francis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-13T20:05:09.000Z","date":"2026-03-12","kind":"sale","planned":true,"acquired":false,"shares":140,"price":11.5224,"value":1613.136,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades during the day at prices ranging from $11.5200 to $11.5450, inclusive. The weighted-average price is reported above. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were completed."}],"balance_after":2502,"source":{"system":"sec-edgar","filing":"0001493152-26-010047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315226010047/ownership.xml","form_type":"4"}},{"id":963012,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-18T18:24:02.000Z","date":"2025-12-16","kind":"other","planned":false,"acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units were issued to the Reporting Person on November 30, 2021 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan and the Restricted Stock Unit Agreement, subject to vesting upon the achievement of specified performance milestones. The applicable milestones were not achieved, and accordingly, the Reporting Person has agreed to voluntarily surrender and cancel the unvested Restricted Stock Units."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-25-028396","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315225028396/ownership.xml","form_type":"4"}},{"id":963718,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71233,"kind":"person","name":"Alavi Hamed","position":1,"cik":"0001964081","reported_name":"Alavi Hamed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-18T17:49:30.000Z","date":"2025-12-16","kind":"other","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units were issued to the Reporting Person on November 30, 2021 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan and the Restricted Stock Unit Agreement, subject to vesting upon the achievement of specified performance milestones. The applicable milestones were not achieved, and accordingly, the Reporting Person has agreed to voluntarily surrender and cancel the unvested Restricted Stock Units."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-25-028394","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1964081/000149315225028394/ownership.xml","form_type":"4"}},{"id":963193,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71199,"kind":"person","name":"Glickman Marc H.","position":1,"cik":"0001730171","reported_name":"Glickman Marc H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-18T17:47:02.000Z","date":"2025-12-16","kind":"other","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units were issued to the Reporting Person on November 30, 2021 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan and the Restricted Stock Unit Agreement, subject to vesting upon the achievement of specified performance milestones. The applicable milestones were not achieved, and accordingly, the Reporting Person has agreed to voluntarily surrender and cancel the unvested Restricted Stock Units."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-25-028392","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730171/000149315225028392/ownership.xml","form_type":"4"}},{"id":968825,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":38541,"kind":"person","name":"Duhay Francis","position":1,"cik":"0001760582","reported_name":"Duhay Francis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-12-16T02:34:33.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":135883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 11, 2025 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2026 calendar year."}],"balance_after":135883,"derivative":{"exercise_price":0.325,"expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":135883},"source":{"system":"sec-edgar","filing":"0001493152-25-027848","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315225027848/ownership.xml","form_type":"4"}},{"id":968824,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-12-16T01:41:49.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":135883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 11, 2025 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended . The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2026 calendar year."}],"balance_after":135883,"derivative":{"exercise_price":0.325,"expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":135883},"source":{"system":"sec-edgar","filing":"0001493152-25-027834","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315225027834/ownership.xml","form_type":"4"}},{"id":968823,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71523,"kind":"person","name":"Shrivastava Sanjay","position":1,"cik":"0001754588","reported_name":"Shrivastava Sanjay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-12-16T01:10:34.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":135883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 11, 2025 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended . The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2026 calendar year."}],"balance_after":135883,"derivative":{"exercise_price":0.325,"expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":135883},"source":{"system":"sec-edgar","filing":"0001493152-25-027826","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315225027826/ownership.xml","form_type":"4"}},{"id":969060,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-12-15T20:40:03.000Z","date":"2025-12-11","kind":"grant","planned":false,"acquired":true,"shares":135883,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 11, 2025 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2026 calendar year."}],"balance_after":135883,"derivative":{"exercise_price":0.325,"expiration_date":"2035-12-11","underlying":"Common Stock","underlying_shares":135883},"source":{"system":"sec-edgar","filing":"0001493152-25-027832","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315225027832/ownership.xml","form_type":"4"}},{"id":970626,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":38541,"kind":"person","name":"Duhay Francis","position":1,"cik":"0001760582","reported_name":"Duhay Francis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-12T21:40:20.000Z","date":"2025-12-11","kind":"sale","planned":true,"acquired":false,"shares":4900,"price":0.3556,"value":1742.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades during the day at prices ranging from $0.3554 to $0.3573, inclusive. The weighted-average price is reported above. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were completed."}],"balance_after":92544,"source":{"system":"sec-edgar","filing":"0001493152-25-027510","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315225027510/ownership.xml","form_type":"4"}},{"id":1037151,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":38541,"kind":"person","name":"Duhay Francis","position":1,"cik":"0001760582","reported_name":"Duhay Francis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-17T13:00:02.000Z","date":"2025-09-15","kind":"sale","planned":true,"acquired":false,"shares":4900,"price":0.83,"value":4067.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades during the day at prices ranging from $0.8205 to $0.84, inclusive. The weighted-average price is reported above. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were completed."}],"balance_after":97444,"source":{"system":"sec-edgar","filing":"0001493152-25-013837","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315225013837/ownership.xml","form_type":"4"}},{"id":1140664,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":79526,"kind":"person","name":"Bright Jennifer","position":1,"cik":"0001937848","reported_name":"Bright Jennifer","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2025-05-20T16:40:04.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options shall vest quarterly, over a three (3) year period, with a one (1) year cliff, subject to the reporting person's continued service with the Company."}],"balance_after":350000,"derivative":{"exercise_price":3.62,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001641172-25-011744","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1937848/000164117225011744/ownership.xml","form_type":"4"}},{"id":1313334,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":38541,"kind":"person","name":"Duhay Francis","position":1,"cik":"0001760582","reported_name":"Duhay Francis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T12:00:20.000Z","date":"2024-12-31","kind":"purchase","planned":false,"acquired":true,"shares":81433,"price":3.07,"value":249999.31,"ownership":{"direct":true},"balance_after":102344,"source":{"system":"sec-edgar","filing":"0001493152-25-000160","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315225000160/ownership.xml","form_type":"4"}},{"id":1318247,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-02T21:05:22.000Z","date":"2024-12-31","kind":"purchase","planned":false,"acquired":true,"shares":3500,"price":2.94,"value":10290.0,"ownership":{"direct":true},"balance_after":11155,"source":{"system":"sec-edgar","filing":"0001493152-25-000058","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315225000058/ownership.xml","form_type":"4"}},{"id":1321463,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71523,"kind":"person","name":"Shrivastava Sanjay","position":1,"cik":"0001754588","reported_name":"Shrivastava Sanjay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-26T21:30:21.000Z","date":"2024-12-24","kind":"purchase","planned":false,"acquired":true,"shares":5400,"price":2.9,"value":15660.0,"ownership":{"direct":true},"balance_after":9288,"source":{"system":"sec-edgar","filing":"0001493152-24-052112","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315224052112/ownership.xml","form_type":"4"}},{"id":1322668,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-23T06:03:16.000Z","date":"2024-12-19","kind":"purchase","planned":false,"acquired":true,"shares":9620,"price":2.53,"value":24338.6,"ownership":{"direct":true},"balance_after":16545,"source":{"system":"sec-edgar","filing":"0001493152-24-051172","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315224051172/ownership.xml","form_type":"4"}},{"id":1323811,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":38541,"kind":"person","name":"Duhay Francis","position":1,"cik":"0001760582","reported_name":"Duhay Francis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-12-21T01:33:17.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":19752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2025 calendar year."}],"balance_after":19752,"derivative":{"exercise_price":2.57,"expiration_date":"2034-12-18","underlying":"Common Stock","underlying_shares":19752},"source":{"system":"sec-edgar","filing":"0001493152-24-051142","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315224051142/ownership.xml","form_type":"4"}},{"id":1323810,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-12-21T01:33:15.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":19752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2025 calendar year."}],"balance_after":19752,"derivative":{"exercise_price":2.57,"expiration_date":"2034-12-18","underlying":"Common Stock","underlying_shares":19752},"source":{"system":"sec-edgar","filing":"0001493152-24-051147","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315224051147/ownership.xml","form_type":"4"}},{"id":1323809,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71523,"kind":"person","name":"Shrivastava Sanjay","position":1,"cik":"0001754588","reported_name":"Shrivastava Sanjay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-12-21T01:33:14.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":19752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2025 calendar year."}],"balance_after":19752,"derivative":{"exercise_price":2.57,"expiration_date":"2034-12-18","underlying":"Common Stock","underlying_shares":19752},"source":{"system":"sec-edgar","filing":"0001493152-24-051148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315224051148/ownership.xml","form_type":"4"}},{"id":1323972,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-12-20T20:33:18.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2027."}],"balance_after":200000,"derivative":{"exercise_price":2.57,"expiration_date":"2034-12-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-24-051146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315224051146/ownership.xml","form_type":"4"}},{"id":1324812,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71233,"kind":"person","name":"Alavi Hamed","position":1,"cik":"0001964081","reported_name":"Alavi Hamed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Options","published_at":"2024-12-20T20:33:14.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2027."}],"balance_after":75000,"derivative":{"exercise_price":2.57,"expiration_date":"2034-12-18","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-24-051143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1964081/000149315224051143/ownership.xml","form_type":"4"}},{"id":1324163,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71199,"kind":"person","name":"Glickman Marc H.","position":1,"cik":"0001730171","reported_name":"Glickman Marc H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Stock Options","published_at":"2024-12-20T20:33:13.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2027."}],"balance_after":75000,"derivative":{"exercise_price":2.57,"expiration_date":"2034-12-18","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-24-051144","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730171/000149315224051144/ownership.xml","form_type":"4"}},{"id":1323935,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-12-20T20:33:13.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":19752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 18, 2024 pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2025 calendar year."}],"balance_after":19752,"derivative":{"exercise_price":2.57,"expiration_date":"2034-12-18","underlying":"Common Stock","underlying_shares":19752},"source":{"system":"sec-edgar","filing":"0001493152-24-051145","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315224051145/ownership.xml","form_type":"4"}},{"id":1325217,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-19T21:51:33.000Z","date":"2024-12-19","kind":"purchase","planned":false,"acquired":true,"shares":12000,"price":2.55,"value":30600.0,"ownership":{"direct":true},"balance_after":222236,"source":{"system":"sec-edgar","filing":"0001493152-24-050865","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315224050865/ownership.xml","form_type":"4"}},{"id":1575638,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71233,"kind":"person","name":"Alavi Hamed","position":1,"cik":"0001964081","reported_name":"Alavi Hamed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Options","published_at":"2024-03-15T20:00:10.000Z","date":"2024-03-13","kind":"exercise","planned":false,"acquired":false,"shares":8334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Amended and Restated 2016 Omnibus Incentive Plan. The award is subject to time-based vesting and will vest in equal quarterly installments during the three calendar years through 2026. The portion of the stock options exercised in this transaction was fully vested and exercisable on the transaction date."}],"balance_after":91666,"derivative":{"exercise_price":3.59,"expiration_date":"2033-12-05","underlying":"Common Stock","underlying_shares":8334},"source":{"system":"sec-edgar","filing":"0001493152-24-010168","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1964081/000149315224010168/ownership.xml","form_type":"4"}},{"id":1575637,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71233,"kind":"person","name":"Alavi Hamed","position":1,"cik":"0001964081","reported_name":"Alavi Hamed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-03-15T20:00:10.000Z","date":"2024-03-13","kind":"sale","planned":false,"acquired":false,"shares":8334,"price":6.22,"value":51837.48,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-24-010168","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1964081/000149315224010168/ownership.xml","form_type":"4"}},{"id":1575636,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71233,"kind":"person","name":"Alavi Hamed","position":1,"cik":"0001964081","reported_name":"Alavi Hamed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2024-03-15T20:00:10.000Z","date":"2024-03-13","kind":"exercise","planned":false,"acquired":true,"shares":8334,"price":3.59,"value":29919.06,"ownership":{"direct":true},"balance_after":8334,"source":{"system":"sec-edgar","filing":"0001493152-24-010168","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1964081/000149315224010168/ownership.xml","form_type":"4"}},{"id":1718830,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-12-07T22:05:57.000Z","date":"2023-12-05","kind":"grant","planned":false,"acquired":true,"shares":13856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2024 calendar year."}],"balance_after":13856,"derivative":{"exercise_price":3.59,"expiration_date":"2033-12-05","underlying":"Common Stock","underlying_shares":13856},"source":{"system":"sec-edgar","filing":"0001493152-23-044058","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315223044058/ownership.xml","form_type":"4"}},{"id":1718829,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71523,"kind":"person","name":"Shrivastava Sanjay","position":1,"cik":"0001754588","reported_name":"Shrivastava Sanjay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-12-07T22:05:55.000Z","date":"2023-12-05","kind":"grant","planned":false,"acquired":true,"shares":13856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2024 calendar year."}],"balance_after":13856,"derivative":{"exercise_price":3.59,"expiration_date":"2033-12-05","underlying":"Common Stock","underlying_shares":13856},"source":{"system":"sec-edgar","filing":"0001493152-23-044060","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315223044060/ownership.xml","form_type":"4"}},{"id":1718828,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":38541,"kind":"person","name":"Duhay Francis","position":1,"cik":"0001760582","reported_name":"Duhay Francis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-12-07T22:05:53.000Z","date":"2023-12-05","kind":"grant","planned":false,"acquired":true,"shares":13856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2024 calendar year."}],"balance_after":13856,"derivative":{"exercise_price":3.59,"expiration_date":"2033-12-05","underlying":"Common Stock","underlying_shares":13856},"source":{"system":"sec-edgar","filing":"0001493152-23-044056","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315223044056/ownership.xml","form_type":"4"}},{"id":1719400,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":107699,"kind":"person","name":"Glynn Craig","position":1,"cik":"0001809590","reported_name":"Glynn Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2023-12-07T17:07:03.000Z","date":"2023-12-05","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2026."}],"balance_after":75000,"derivative":{"exercise_price":3.59,"expiration_date":"2033-12-05","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-23-044062","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809590/000149315223044062/ownership.xml","form_type":"4"}},{"id":1718913,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-12-07T17:06:00.000Z","date":"2023-12-05","kind":"grant","planned":false,"acquired":true,"shares":13856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2024 calendar year."}],"balance_after":13856,"derivative":{"exercise_price":3.59,"expiration_date":"2033-12-05","underlying":"Common Stock","underlying_shares":13856},"source":{"system":"sec-edgar","filing":"0001493152-23-044059","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315223044059/ownership.xml","form_type":"4"}},{"id":1719454,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71233,"kind":"person","name":"Alavi Hamed","position":1,"cik":"0001964081","reported_name":"Alavi Hamed","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Options","published_at":"2023-12-07T17:05:59.000Z","date":"2023-12-05","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2026."}],"balance_after":100000,"derivative":{"exercise_price":3.59,"expiration_date":"2033-12-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-23-044054","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1964081/000149315223044054/ownership.xml","form_type":"4"}},{"id":1719113,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71199,"kind":"person","name":"Glickman Marc H.","position":1,"cik":"0001730171","reported_name":"Glickman Marc H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Stock Options","published_at":"2023-12-07T17:05:58.000Z","date":"2023-12-05","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2026."}],"balance_after":100000,"derivative":{"exercise_price":3.59,"expiration_date":"2033-12-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-23-044057","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730171/000149315223044057/ownership.xml","form_type":"4"}},{"id":1718977,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2023-12-07T17:05:52.000Z","date":"2023-12-05","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on December 5, 2023 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2026."}],"balance_after":300000,"derivative":{"exercise_price":3.59,"expiration_date":"2033-12-05","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-23-044055","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315223044055/ownership.xml","form_type":"4"}},{"id":2097743,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71523,"kind":"person","name":"Shrivastava Sanjay","position":1,"cik":"0001754588","reported_name":"Shrivastava Sanjay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-12-02T21:30:37.000Z","date":"2022-11-30","kind":"grant","acquired":true,"shares":8403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on November 30, 2022 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2023 calendar year."}],"balance_after":8403,"derivative":{"exercise_price":6.7,"expiration_date":"2032-11-30","underlying":"Common Stock","underlying_shares":8403},"source":{"system":"sec-edgar","filing":"0001493152-22-034307","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315222034307/ownership.xml","form_type":"4"}},{"id":2097742,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-12-02T21:30:31.000Z","date":"2022-11-30","kind":"grant","acquired":true,"shares":8403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on November 30, 2022 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2023 calendar year."}],"balance_after":8403,"derivative":{"exercise_price":6.7,"expiration_date":"2032-11-30","underlying":"Common Stock","underlying_shares":8403},"source":{"system":"sec-edgar","filing":"0001493152-22-034315","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315222034315/ownership.xml","form_type":"4"}},{"id":2097739,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":38541,"kind":"person","name":"Duhay Francis","position":1,"cik":"0001760582","reported_name":"Duhay Francis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-12-02T21:30:21.000Z","date":"2022-11-30","kind":"grant","acquired":true,"shares":8403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on November 30, 2022 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2023 calendar year."}],"balance_after":8403,"derivative":{"exercise_price":6.7,"expiration_date":"2032-11-30","underlying":"Common Stock","underlying_shares":8403},"source":{"system":"sec-edgar","filing":"0001493152-22-034316","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315222034316/ownership.xml","form_type":"4"}},{"id":2097910,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-12-02T16:30:43.000Z","date":"2022-11-30","kind":"grant","acquired":true,"shares":8403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on November 30, 2022 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2023 calendar year."}],"balance_after":8403,"derivative":{"exercise_price":6.7,"expiration_date":"2032-11-30","underlying":"Common Stock","underlying_shares":8403},"source":{"system":"sec-edgar","filing":"0001493152-22-034312","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315222034312/ownership.xml","form_type":"4"}},{"id":2156915,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-09-16T20:05:22.000Z","date":"2022-09-13","kind":"exercise","acquired":false,"shares":1041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") converts into one share of common stock of enVVeno Medical Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of the RSUs occurred in September 2020, 2021 and 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of the RSUs occurred in September 2020, 2021 and 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1041},"source":{"system":"sec-edgar","filing":"0001493152-22-026071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315222026071/ownership.xml","form_type":"4"}},{"id":2156914,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-16T20:05:22.000Z","date":"2022-09-13","kind":"exercise","acquired":true,"shares":1041,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") converts into one share of common stock of enVVeno Medical Corporation."}],"balance_after":7655,"source":{"system":"sec-edgar","filing":"0001493152-22-026071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315222026071/ownership.xml","form_type":"4"}},{"id":2157089,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-09-16T16:05:21.000Z","date":"2022-09-13","kind":"exercise","acquired":false,"shares":1041,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") converts into one share of common stock of enVVeno Medical Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of the RSUs occurred in September 2020, 2021 and 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of the RSUs occurred in September 2020, 2021 and 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1041},"source":{"system":"sec-edgar","filing":"0001493152-22-026070","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315222026070/ownership.xml","form_type":"4"}},{"id":2157088,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-16T16:05:21.000Z","date":"2022-09-13","kind":"exercise","acquired":true,"shares":1041,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") converts into one share of common stock of enVVeno Medical Corporation."}],"balance_after":6925,"source":{"system":"sec-edgar","filing":"0001493152-22-026070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315222026070/ownership.xml","form_type":"4"}},{"id":2179050,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":38541,"kind":"person","name":"Duhay Francis","position":1,"cik":"0001760582","reported_name":"Duhay Francis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-18T20:05:41.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":7751,"price":6.14,"value":47591.14,"ownership":{"direct":true},"balance_after":20911,"source":{"system":"sec-edgar","filing":"0001493152-22-023461","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315222023461/ownership.xml","form_type":"4"}},{"id":2216700,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71523,"kind":"person","name":"Shrivastava Sanjay","position":1,"cik":"0001754588","reported_name":"Shrivastava Sanjay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-01T20:05:41.000Z","date":"2022-06-30","kind":"purchase","acquired":true,"shares":1000,"price":3.85,"value":3850.0,"ownership":{"direct":true},"balance_after":3888,"source":{"system":"sec-edgar","filing":"0001493152-22-018361","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315222018361/ownership.xml","form_type":"4"}},{"id":2220067,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-06-28T16:05:47.000Z","date":"2022-06-27","kind":"purchase","acquired":true,"shares":2500,"price":3.8,"value":9500.0,"ownership":{"direct":true},"balance_after":210236,"source":{"system":"sec-edgar","filing":"0001493152-22-017957","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315222017957/ownership.xml","form_type":"4"}},{"id":2488065,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-12-02T21:05:50.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":7211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on November 30, 2021 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2022 calendar year."}],"balance_after":7211,"derivative":{"exercise_price":6.7,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":7211},"source":{"system":"sec-edgar","filing":"0001493152-21-030305","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315221030305/ownership.xml","form_type":"4"}},{"id":2488064,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":38541,"kind":"person","name":"Duhay Francis","position":1,"cik":"0001760582","reported_name":"Duhay Francis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-12-02T21:05:48.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":7211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on November 30, 2021 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2022 calendar year."}],"balance_after":7211,"derivative":{"exercise_price":6.7,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":7211},"source":{"system":"sec-edgar","filing":"0001493152-21-030304","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315221030304/ownership.xml","form_type":"4"}},{"id":2488063,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71523,"kind":"person","name":"Shrivastava Sanjay","position":1,"cik":"0001754588","reported_name":"Shrivastava Sanjay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-12-02T21:05:43.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":7211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on November 30, 2021 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2022 calendar year."}],"balance_after":7211,"derivative":{"exercise_price":6.7,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":7211},"source":{"system":"sec-edgar","filing":"0001493152-21-030301","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315221030301/ownership.xml","form_type":"4"}},{"id":2488442,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2021-12-02T18:27:58.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":349781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The common stock options were issued to the Reporting Person on November 30, 2021 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2024."}],"balance_after":349781,"derivative":{"exercise_price":6.7,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":349781},"source":{"system":"sec-edgar","filing":"0001493152-21-030335","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315221030335/ownership.xml","form_type":"4"}},{"id":2488441,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-02T18:27:58.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted 200,000 restricted stock units on November 30, 2021 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The restricted stock units are subject to milestone-based vesting as follows: (i) 50% upon SAVVE (Surgical Anti-reflux Venous Valve Endoprosthesis) endpoints being achieved, and (ii) 50% upon the Pre-Market Approval of the VenoValve."}],"balance_after":207736,"source":{"system":"sec-edgar","filing":"0001493152-21-030335","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315221030335/ownership.xml","form_type":"4"}},{"id":2488852,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71199,"kind":"person","name":"Glickman Marc H.","position":1,"cik":"0001730171","reported_name":"Glickman Marc H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Stock Options","published_at":"2021-12-02T18:26:24.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":265700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The common stock options were issued to the Reporting Person on November 30, 2021 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2024."}],"balance_after":265700,"derivative":{"exercise_price":6.7,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":265700},"source":{"system":"sec-edgar","filing":"0001493152-21-030333","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1730171/000149315221030333/ownership.xml","form_type":"4"}},{"id":2488851,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71199,"kind":"person","name":"Glickman Marc H.","position":1,"cik":"0001730171","reported_name":"Glickman Marc H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-12-02T18:26:24.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted 100,000 restricted stock units on November 30, 2021 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The restricted stock units are subject to milestone-based vesting as follows: (i) 50% upon SAVVE (Surgical Anti-reflux Venous Valve Endoprosthesis) endpoints being achieved, and (ii) 50% upon the Pre-Market Approval of the VenoValve."}],"balance_after":101600,"source":{"system":"sec-edgar","filing":"0001493152-21-030333","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730171/000149315221030333/ownership.xml","form_type":"4"}},{"id":2489667,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":107699,"kind":"person","name":"Glynn Craig","position":1,"cik":"0001809590","reported_name":"Glynn Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Options","published_at":"2021-12-02T18:25:16.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":125925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The common stock options were issued to the Reporting Person on November 30, 2021 pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the three calendar years through 2024."}],"balance_after":125925,"derivative":{"exercise_price":6.7,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":125925},"source":{"system":"sec-edgar","filing":"0001493152-21-030331","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1809590/000149315221030331/ownership.xml","form_type":"4"}},{"id":2489666,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":107699,"kind":"person","name":"Glynn Craig","position":1,"cik":"0001809590","reported_name":"Glynn Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-02T18:25:16.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted 50,000 restricted stock units on November 30, 2021 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The restricted stock units are subject to milestone-based vesting as follows: (i) 50% upon SAVVE (Surgical Anti-reflux Venous Valve Endoprosthesis) endpoints being achieved, and (ii) 50% upon the Pre-Market Approval of the VenoValve."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001493152-21-030331","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809590/000149315221030331/ownership.xml","form_type":"4"}},{"id":2488292,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-12-02T16:05:45.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":7211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The common stock options were issued to the Reporting Person on November 30, 2021 pursuant to the issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\"). The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2022 calendar year."}],"balance_after":7211,"derivative":{"exercise_price":6.7,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":7211},"source":{"system":"sec-edgar","filing":"0001493152-21-030303","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315221030303/ownership.xml","form_type":"4"}},{"id":2502469,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-11-19T17:27:48.000Z","date":"2021-11-19","kind":"purchase","acquired":true,"shares":2000,"price":7.43,"value":14860.0,"ownership":{"direct":true},"balance_after":7736,"source":{"system":"sec-edgar","filing":"0001493152-21-029430","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315221029430/ownership.xml","form_type":"4"}},{"id":2504245,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71523,"kind":"person","name":"Shrivastava Sanjay","position":1,"cik":"0001754588","reported_name":"Shrivastava Sanjay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-11-18T21:30:03.000Z","date":"2021-11-16","kind":"exercise","acquired":false,"shares":388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") converts into one share of common stock of enVVeno Medical Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were issued to the Reporting person on November 27, 2018, in connection with joining the Issuer's board of directors pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (as amended, the \"Plan\"), subject to vesting and settlement as described in the person's Form 4, as filed on November 6, 2019. The vesting and settlement of 388 RSUs occurred on November 16, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were issued to the Reporting person on November 27, 2018, in connection with joining the Issuer's board of directors pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (as amended, the \"Plan\"), subject to vesting and settlement as described in the person's Form 4, as filed on November 6, 2019. The vesting and settlement of 388 RSUs occurred on November 16, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":388},"source":{"system":"sec-edgar","filing":"0001493152-21-029234","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315221029234/ownership.xml","form_type":"4"}},{"id":2504244,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71523,"kind":"person","name":"Shrivastava Sanjay","position":1,"cik":"0001754588","reported_name":"Shrivastava Sanjay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-18T21:30:03.000Z","date":"2021-11-16","kind":"exercise","acquired":true,"shares":388,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The RSUs were issued to the Reporting person on November 27, 2018, in connection with joining the Issuer's board of directors pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (as amended, the \"Plan\"), subject to vesting and settlement as described in the person's Form 4, as filed on November 6, 2019. The vesting and settlement of 388 RSUs occurred on November 16, 2021."}],"balance_after":2888,"source":{"system":"sec-edgar","filing":"0001493152-21-029234","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315221029234/ownership.xml","form_type":"4"}},{"id":2504563,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2021-11-18T16:24:11.000Z","date":"2021-11-16","kind":"purchase","acquired":true,"shares":2000,"price":7.87,"value":15740.0,"ownership":{"direct":true},"balance_after":5736,"source":{"system":"sec-edgar","filing":"0001493152-21-029229","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315221029229/ownership.xml","form_type":"4"}},{"id":2568645,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-09-16T01:50:12.000Z","date":"2021-09-13","kind":"exercise","acquired":false,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") converts into one share of common stock of Hancock Jaffe Laboratories, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on September 26, 2020. The vesting and settlement of 1,042 RSUs occurred on September 13, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on September 26, 2020. The vesting and settlement of 1,042 RSUs occurred on September 13, 2021."}],"balance_after":2084,"derivative":{"underlying":"Common Stock","underlying_shares":1042},"source":{"system":"sec-edgar","filing":"0001493152-21-022862","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315221022862/ownership.xml","form_type":"4"}},{"id":2568644,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-16T01:50:12.000Z","date":"2021-09-13","kind":"exercise","acquired":true,"shares":1042,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") converts into one share of common stock of Hancock Jaffe Laboratories, Inc."}],"balance_after":6614,"source":{"system":"sec-edgar","filing":"0001493152-21-022862","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315221022862/ownership.xml","form_type":"4"}},{"id":2568784,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-09-15T21:50:17.000Z","date":"2021-09-13","kind":"exercise","acquired":false,"shares":1042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") converts into one share of common stock of Hancock Jaffe Laboratories, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of 1,042 RSUs occurred on September 13, 2021"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of 1,042 RSUs occurred on September 13, 2021"}],"balance_after":2084,"derivative":{"underlying":"Common Stock","underlying_shares":1042},"source":{"system":"sec-edgar","filing":"0001493152-21-022863","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315221022863/ownership.xml","form_type":"4"}},{"id":2568783,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T21:50:17.000Z","date":"2021-09-13","kind":"exercise","acquired":true,"shares":1042,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") converts into one share of common stock of Hancock Jaffe Laboratories, Inc."}],"balance_after":5884,"source":{"system":"sec-edgar","filing":"0001493152-21-022863","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315221022863/ownership.xml","form_type":"4"}},{"id":2587829,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $$0.00001 par value","published_at":"2021-08-27T15:19:33.000Z","date":"2021-08-25","kind":"purchase","acquired":true,"shares":1300,"price":7.7,"value":10010.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 25, 2021, the reporting person purchased 1,300 shares of common stock in the public market at $7.70 per share."}],"balance_after":4842,"source":{"system":"sec-edgar","filing":"0001493152-21-021444","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315221021444/ownership.xml","form_type":"4"}},{"id":2659912,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T23:16:28.000Z","date":"2021-06-16","kind":"purchase","acquired":true,"shares":2000,"price":6.25,"value":12500.0,"ownership":{"direct":true},"balance_after":5572,"source":{"system":"sec-edgar","filing":"0001493152-21-014906","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315221014906/ownership.xml","form_type":"4"}},{"id":2697050,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71199,"kind":"person","name":"Glickman Marc H.","position":1,"cik":"0001730171","reported_name":"Glickman Marc H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-25T17:15:44.000Z","date":"2021-05-21","kind":"purchase","acquired":true,"shares":1600,"price":5.9,"value":9440.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 21, 2021, the reporting person purchased 1,600 shares of common stock on the open market at $5.90 per share."}],"balance_after":1600,"source":{"system":"sec-edgar","filing":"0001493152-21-012878","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730171/000149315221012878/ownership.xml","form_type":"4"}},{"id":2704785,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":38541,"kind":"person","name":"Duhay Francis","position":1,"cik":"0001760582","reported_name":"Duhay Francis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $$0.00001 par value","published_at":"2021-05-20T00:18:23.000Z","date":"2021-05-17","kind":"purchase","acquired":true,"shares":9492,"price":5.33,"value":50592.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person acquired these shares of common stock on the open market."}],"balance_after":13160,"source":{"system":"sec-edgar","filing":"0001493152-21-012296","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315221012296/ownership.xml","form_type":"4"}},{"id":2705157,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.00001 par value","published_at":"2021-05-19T20:20:49.000Z","date":"2021-05-18","kind":"purchase","acquired":true,"shares":3000,"price":5.47,"value":16410.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person acquired these shares of common stock on the open market."}],"balance_after":3736,"source":{"system":"sec-edgar","filing":"0001493152-21-012298","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315221012298/ownership.xml","form_type":"4"}},{"id":2841021,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":107699,"kind":"person","name":"Glynn Craig","position":1,"cik":"0001809590","reported_name":"Glynn Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2021-02-23T17:21:15.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":324000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest in equal quarterly installments over a three year period, however the stock options may only become exercisable following receipt by the registrant of stockholder approval to increase the size of the Plan sufficiently to permit the exercise in full of such stock options under the Plan. If the registrant's stockholders do not approve an increase in the size of the Plan, the options will be void."}],"balance_after":324,"derivative":{"exercise_price":8.2,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":324},"source":{"system":"sec-edgar","filing":"0001493152-21-004623","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1809590/000149315221004623/ownership.xml","form_type":"4"}},{"id":2841020,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":107699,"kind":"person","name":"Glynn Craig","position":1,"cik":"0001809590","reported_name":"Glynn Craig","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2021-02-23T17:21:15.000Z","date":"2020-07-18","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in equal quarterly installments over a three year period commencing October 18, 2020."}],"balance_after":4000,"derivative":{"exercise_price":10,"expiration_date":"2030-07-18","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001493152-21-004623","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1809590/000149315221004623/ownership.xml","form_type":"4"}},{"id":2842625,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":38541,"kind":"person","name":"Duhay Francis","position":1,"cik":"0001760582","reported_name":"Duhay Francis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-02-23T02:59:01.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":5673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The common stock options were issued to the reporting person as part of the annual board compensation package for 2021. The award is subject to time-based vesting and will vest in equal quarterly portions over the remainder of the 2021 calendar year."}],"balance_after":5673,"derivative":{"exercise_price":8.2,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":5673},"source":{"system":"sec-edgar","filing":"0001493152-21-004537","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315221004537/ownership.xml","form_type":"4"}},{"id":2842624,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71523,"kind":"person","name":"Shrivastava Sanjay","position":1,"cik":"0001754588","reported_name":"Shrivastava Sanjay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-02-23T02:57:47.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":5673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The common stock options were issued to the reporting person as part of the annual board compensation package for 2021. The award is subject to time-based vesting and will vest in equal quarterly portions over the remainder of the 2021 calendar year."}],"balance_after":5673,"derivative":{"exercise_price":8.2,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":5673},"source":{"system":"sec-edgar","filing":"0001493152-21-004533","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315221004533/ownership.xml","form_type":"4"}},{"id":2842623,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71524,"kind":"person","name":"Gray Robert","position":1,"cik":"0001788480","reported_name":"Gray Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-02-23T02:56:48.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":5673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The common stock options were issued to the reporting person as part of the annual board compensation package for 2021. The award is subject to time-based vesting and will vest in equal quarterly portions over the remainder of the 2021 calendar year."}],"balance_after":5673,"derivative":{"exercise_price":8.2,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":5673},"source":{"system":"sec-edgar","filing":"0001493152-21-004529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315221004529/ownership.xml","form_type":"4"}},{"id":2842837,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-02-22T21:58:04.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":5673,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\").."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The common stock options were issued to the reporting person as part of the annual board compensation package for 2021. The award is subject to time-based vesting and will vest in equal quarterly portions over the remainder of the 2021 calendar year."}],"balance_after":5673,"derivative":{"exercise_price":8.2,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":5673},"source":{"system":"sec-edgar","filing":"0001493152-21-004534","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315221004534/ownership.xml","form_type":"4"}},{"id":2842962,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71185,"kind":"person","name":"BERMAN ROBERT ANDREW","position":1,"cik":"0001258360","reported_name":"BERMAN ROBERT ANDREW","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option","published_at":"2021-02-22T21:56:49.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":838000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest in equal quarterly installments over a two a year period, however the stock options may only become exercisable following receipt by the registrant of stockholder approval to increase the size of the Plan sufficiently to permit the exercise in full of such stock options under the Plan. If the registrant's stockholders do not approve an increase in the size of the Plan, the options will be void."}],"balance_after":838000,"derivative":{"exercise_price":8.2,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":838000},"source":{"system":"sec-edgar","filing":"0001493152-21-004530","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258360/000149315221004530/ownership.xml","form_type":"4"}},{"id":2843396,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71199,"kind":"person","name":"Glickman Marc H.","position":1,"cik":"0001730171","reported_name":"Glickman Marc H.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & CMO"}}],"security":"Stock Option","published_at":"2021-02-22T21:56:07.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":406000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option was granted pursuant to the registrant's Amended and Restated 2016 Omnibus Incentive Plan, as amended (the \"Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest in equal quarterly installments over a two a year period, however the stock options may only become exercisable following receipt by the registrant of stockholder approval to increase the size of the Plan sufficiently to permit the exercise in full of such stock options under the Plan. If the registrant's stockholders do not approve an increase in the size of the Plan, the options will be void."}],"balance_after":406000,"derivative":{"exercise_price":8.2,"expiration_date":"2031-02-18","underlying":"Common Stock","underlying_shares":406000},"source":{"system":"sec-edgar","filing":"0001493152-21-004528","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1730171/000149315221004528/ownership.xml","form_type":"4"}},{"id":3001989,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-21T16:05:33.000Z","date":"2020-07-18","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The common stock options were issued to the Reporting Person pursuant to the Plan on July 18, 2020 as part of the annual board compensation package for 2020. The award is subject to time-based vesting and will vest in equal quarterly portions over the remainder of the 2020 calendar year."}],"balance_after":100000,"derivative":{"exercise_price":0.4,"expiration_date":"2030-07-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-20-019736","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315220019736/ownership.xml","form_type":"4"}},{"id":3001988,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-21T16:05:33.000Z","date":"2019-09-13","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The common stock options were issued to the Reporting Person on September 13, 2019 in connection with joining the Issuer's board of directors pursuant to the Plan. The award is subject to time-based vesting and will vest in equal quarterly portions over a three (3) year period starting from September 13, 2019."}],"balance_after":60000,"derivative":{"exercise_price":2,"expiration_date":"2029-09-13","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001493152-20-019736","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315220019736/ownership.xml","form_type":"4"}},{"id":3001987,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-10-21T16:05:33.000Z","date":"2019-09-13","kind":"grant","acquired":true,"shares":78125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each Restricted Stock Unit (\"RSU\") entitles the Reporting Person to one share of the Issuer's common stock or the cash equivalent, at the discretion of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSU were issued to the Reporting Person on September 13, 2019 in connection with joining the Issuer's board of directors pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (as amended, the \"Plan\"). The award is subject to time-based vesting and will vest in equal annual portions on: (i) September 13, 2020; (ii) September 13, 2021; and (iii) September 13, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU were issued to the Reporting Person on September 13, 2019 in connection with joining the Issuer's board of directors pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (as amended, the \"Plan\"). The award is subject to time-based vesting and will vest in equal annual portions on: (i) September 13, 2020; (ii) September 13, 2021; and (iii) September 13, 2022."}],"balance_after":78125,"derivative":{"underlying":"Common Stock","underlying_shares":78125},"source":{"system":"sec-edgar","filing":"0001493152-20-019736","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315220019736/ownership.xml","form_type":"4"}},{"id":3001986,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":71539,"kind":"person","name":"Jenusaitis Matthew","position":1,"cik":"0001357864","reported_name":"Jenusaitis Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-21T16:05:33.000Z","date":"2020-07-18","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":62500,"source":{"system":"sec-edgar","filing":"0001493152-20-019736","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357864/000149315220019736/ownership.xml","form_type":"4"}},{"id":3018082,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-08-21","kind":"sale","acquired":false,"shares":75000,"price":0.38,"value":28500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1405433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018081,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-08-20","kind":"sale","acquired":false,"shares":75000,"price":0.27,"value":20250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1480433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018080,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-08-19","kind":"sale","acquired":false,"shares":50000,"price":0.3,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1555433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018079,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-08-18","kind":"sale","acquired":false,"shares":50000,"price":0.34,"value":17000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1605433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018078,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-08-14","kind":"sale","acquired":false,"shares":50000,"price":0.31,"value":15500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1655433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018077,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":70000,"price":0.32,"value":22400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1705433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018076,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-07-31","kind":"sale","acquired":false,"shares":5000,"price":0.34,"value":1700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1775433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018075,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-07-30","kind":"sale","acquired":false,"shares":25000,"price":0.32,"value":8000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1780433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018074,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-07-21","kind":"sale","acquired":false,"shares":50000,"price":0.45,"value":22500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1805433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018073,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-07-20","kind":"sale","acquired":false,"shares":150000,"price":0.43,"value":64500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":1855433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018072,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-07-17","kind":"sale","acquired":false,"shares":50000,"price":0.38,"value":19000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2005433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018071,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-07-16","kind":"sale","acquired":false,"shares":50000,"price":0.38,"value":19000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2055433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018070,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-07-06","kind":"sale","acquired":false,"shares":6450,"price":0.39,"value":2515.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2105433,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018069,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-07-02","kind":"sale","acquired":false,"shares":57000,"price":0.4,"value":22800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2111883,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018068,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":45000,"price":0.38,"value":17100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2168883,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018067,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-06-29","kind":"sale","acquired":false,"shares":68094,"price":0.39,"value":26556.66,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2213883,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018066,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-06-26","kind":"sale","acquired":false,"shares":80000,"price":0.38,"value":30400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2281977,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}},{"id":3018065,"issuer":{"id":8104,"kind":"organization","name":"enVVeno Medical Corp","symbol":"NVNO"},"owners":[{"id":146306,"kind":"organization","name":"Biodyne Holding, S.A.","position":1,"cik":"0001730174","reported_name":"Biodyne Holding, S.A.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2020-10-02T01:25:50.000Z","date":"2020-06-25","kind":"sale","acquired":false,"shares":100000,"price":0.4,"value":40000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4."}],"balance_after":2361977,"source":{"system":"sec-edgar","filing":"0001493152-20-018750","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1661053/000149315220018750/ownership.xml","form_type":"4"}}],"next_cursor":"2020-10-02T01:25:50.000000Z,3018065"}